Qube Research & Technologies Ltd - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$46,947
-94.8%
10,318
-92.0%
0.00%
-100.0%
Q2 2023$908,843
+51.7%
129,097
+31.7%
0.00%0.0%
Q1 2023$598,969
-49.6%
98,031
-47.3%
0.00%
-50.0%
Q4 2022$1,188,252
+353.5%
185,955
+3190.1%
0.01%
+50.0%
Q4 2020$262,000
-31.2%
5,652
-51.2%
0.00%
-20.0%
Q3 2020$381,000
-76.6%
11,586
-80.5%
0.01%
-79.2%
Q2 2020$1,629,000
+45.2%
59,339
+46.4%
0.02%
-31.4%
Q4 2019$1,122,00040,5220.04%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders